首页> 外文期刊>Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology >Nonsustained polymorphic ventricular tachycardia during adenosine stress perfusion imaging in the setting of resting pre-excitation electrocardiographic pattern: should we be avoiding adenosine pharmacologic stress testing in pre-excitation syndromes
【24h】

Nonsustained polymorphic ventricular tachycardia during adenosine stress perfusion imaging in the setting of resting pre-excitation electrocardiographic pattern: should we be avoiding adenosine pharmacologic stress testing in pre-excitation syndromes

机译:静止的兴奋前心电图模式下腺苷应力灌注显像期间的非持续性多态性室性心动过速:应避免在兴奋前综合征中使用腺苷药理学压力测试

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Adenosine is an endogenous nucleoside that is ubiquitous within the human body. It is a nonselective A2 receptor antagonist. Through its action on the A2A receptor, adenosine induces direct coronary arteriolar vasodilatation and is well suited as a pharmacologic agent in the assessment of myocardial ischemia.Adenosine is known to have a very favorable and excellent safety profile. Through its other actions on the Aj, A2B, and A3 receptors, it can produce some uncommon yet serious side effects. These include high-grade atrioventricular (AV) block, hypotension (through its vasodilatory properties on the peripheral vasculature), and severe bronchospasm (and therefore is contraindi-cated in patients with severe reactive airway disease). Because of its extremely short half-life (approximately 5 seconds), these effects usually spontaneously resolve upon cessation of the adenosine infusion.We describe a case of sudden onset of nonsustained polymorphic ventricular tachycardia in a patient with known Wolff-Parkinson-White (WPW) pattern (delta wave) on resting electrocardiogram (ECG) during adenosine infusion for a myocardial perfusion study. This case report raises questions as to whether pre-excitation pattern or syndromes should be considered a contraindication for adenosine stress perfusion imaging.
机译:背景。腺苷是人体中普遍存在的内源性核苷。它是一种非选择性的A2受体拮抗剂。腺苷通过对A2A受体的作用而诱导直接的冠状小动脉血管舒张,非常适合作为评估心肌缺血的药物。众所周知,腺苷具有非常良好的安全性。通过对Aj,A2B和A3受体的其他作用,它可能会产生一些罕见但严重的副作用。这些包括高度房室传导阻滞,低血压(通过其在外周血管上的血管舒张特性)和严重的支气管痉挛(因此在严重的反应性气道疾病患者中禁用)。由于其半衰期极短(约5秒),这些作用通常在腺苷输注停止后自发解决。我们描述了一例在患有已知Wolff-Parkinson-White(WPW)的患者中突然出现非持续性多态性室性心动过速)在腺苷输注过程中静息心电图(ECG)上的模式(δ波),用于心肌灌注研究。该病例报告提出了关于应将兴奋前模式或综合症视为腺苷应激灌注成像的禁忌症的问题。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号